These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2235 related articles for article (PubMed ID: 30088453)
1. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453 [TBL] [Abstract][Full Text] [Related]
2. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition. Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976 [TBL] [Abstract][Full Text] [Related]
3. Algerian propolis: between protection of normal cells and potentialisation of the anticancer effects of doxorubicin against breast cancer cells via P-glycoprotein inhibition and cell cycle arrest in the S phase. Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmaileh B; Mansour Al Shhab MA; Al-Ameer HJ; Mustafa E J Physiol Pharmacol; 2021 Apr; 72(2):. PubMed ID: 34374660 [TBL] [Abstract][Full Text] [Related]
4. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line. Toffoli G; Corona G; Gigante M; Boiocchi M Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123 [TBL] [Abstract][Full Text] [Related]
6. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin. Xue C; Wang C; Sun Y; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Ma X; Peng J; Liu K Oncotarget; 2017 Jan; 8(5):8622-8632. PubMed ID: 28052008 [TBL] [Abstract][Full Text] [Related]
7. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation. Zhang ZL; Jiang QC; Wang SR Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822 [TBL] [Abstract][Full Text] [Related]
8. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells. Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065 [TBL] [Abstract][Full Text] [Related]
9. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385 [TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin. Zong L; Cheng G; Liu S; Pi Z; Liu Z; Song F J Pharm Biomed Anal; 2019 Feb; 165():268-275. PubMed ID: 30572191 [TBL] [Abstract][Full Text] [Related]
11. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
12. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter. Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440 [TBL] [Abstract][Full Text] [Related]
13. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Xu HB; Li L; Liu GQ Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169 [TBL] [Abstract][Full Text] [Related]
14. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe. Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750 [TBL] [Abstract][Full Text] [Related]
15. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation. Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430 [TBL] [Abstract][Full Text] [Related]
16. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells. Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804 [TBL] [Abstract][Full Text] [Related]
17. Asiatic Acid (AA) Sensitizes Multidrug-Resistant Human Lung Adenocarcinoma A549/DDP Cells to Cisplatin (DDP) via Downregulation of P-Glycoprotein (MDR1) and Its Targets. Cheng Q; Liao M; Hu H; Li H; Wu L Cell Physiol Biochem; 2018; 47(1):279-292. PubMed ID: 29768255 [TBL] [Abstract][Full Text] [Related]
18. The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic enzymes. Eid SY; Althubiti MA; Abdallah ME; Wink M; El-Readi MZ Phytomedicine; 2020 Oct; 77():153280. PubMed ID: 32712543 [TBL] [Abstract][Full Text] [Related]
19. Effects of P-glycoprotein and its inhibitors on apoptosis in K562 cells. Zu Y; Yang Z; Tang S; Han Y; Ma J Molecules; 2014 Aug; 19(9):13061-75. PubMed ID: 25157469 [TBL] [Abstract][Full Text] [Related]
20. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells. Han F; Liu G; Sun C; Wei J Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):55-61. PubMed ID: 30672437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]